STK4 regulates TLR pathways and protects against chronic inflammation–related hepatocellular carcinoma

Published in Volume 135, Issue 8 on April 15, 2025
J Clin Invest. 2025;135(8):e193453. https://doi.org/10.1172/JCI193453.
© 2025 Li et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Original citation: J Clin Invest. 2015;125(11):4239-4254. https://doi.org/10.1172/JCI81203

Citation for this corrigendum: J Clin Invest. 2025;135(8):e193453. https://doi.org/10.1172/JCI193453

The authors recently became aware that in Figure 8D of the original article, the two representative images for the Stk4ΔM/ΔM group were different crops of the same image. The correct panel, showing independent biological replicates provided from the original source data, is shown below:

STK4 protects mice from DEN and bacterial infection-induced HCC in vivo.Figure 8

STK4 protects mice from DEN and bacterial infection-induced HCC in vivo.

Footnotes

Comments (0)

No login
gif